Literature DB >> 3828764

A comparative study on characterization and distribution of cholecystokinin binding sites among the rat, mouse and guinea pig brain.

R Sekiguchi, T Moroji.   

Abstract

Using the in vitro quantitative receptor autoradiographical technique, [propionyl-3H]propionylated cholecystokinin octapeptide ([3H]pCCK-8) binding sites were investigated in tissue sections of rat, mouse and guinea pig brains. In all the tested animals, [3H]pCCK-8 bound very slowly to the tissue sections. Dissociation was also slow, and had a biphasic profile suggesting CCK-8 binding sites are heterogeneous. Dissociation rate constants were, however, unequal among these species. In the saturation binding studies, both Bmax and (Kd)app values varied among the animal species. The autoradiograms revealed marked species differences in [3H]pCCK-8 binding sites in the brain among 3 closely related species of rodents. [3H]pCCK-8 binding sites were undetectable in the nucleus accumbens/caudate-putamen and the amygdaloid complex of the mouse brain, and scarcely found in the ventromedialis of the hypothalamus of the mouse and guinea pig brain. Furthermore, moderate-to-high densities of [3H]pCCK-8 binding sites were observed in the cerebella of the mouse and guinea pig, whereas in the rat cerebellum the binding sites were undetected. The above-mentioned observations suggest the existence of species differences in the binding pattern of CCK-like peptides among closely related animal species. Furthermore, it would appear that CCK-like peptides in the brain may play different physiological roles among animal species.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3828764     DOI: 10.1016/0006-8993(86)91517-9

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  6 in total

1.  Visualization of neuropeptide-binding sites on individual telencephalic neurons of the rat.

Authors:  B Krisch; C Buchholz; R Mentlein; A Turzynski
Journal:  Cell Tissue Res       Date:  1993-06       Impact factor: 5.249

2.  Cholecystokinin and psychiatric disorders : role in aetiology and potential of receptor antagonists in therapy.

Authors:  J Shlik; E Vasar; J Bradwejn
Journal:  CNS Drugs       Date:  1997-08       Impact factor: 5.749

3.  Interaction between the cholecystokinin and endogenous cannabinoid systems in cued fear expression and extinction retention.

Authors:  Mallory E Bowers; Kerry J Ressler
Journal:  Neuropsychopharmacology       Date:  2014-09-01       Impact factor: 7.853

4.  Cholecystokinin binding sites in the rat forebrain: effects of acute and chronic methamphetamine administration.

Authors:  T Suzuki; T Moroji
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

5.  The cholecystokinin-A receptor mediates inhibition of food intake yet is not essential for the maintenance of body weight.

Authors:  A S Kopin; W F Mathes; E W McBride; M Nguyen; W Al-Haider; F Schmitz; S Bonner-Weir; R Kanarek; M Beinborn
Journal:  J Clin Invest       Date:  1999-02       Impact factor: 14.808

6.  Functional synergy between cholecystokinin receptors CCKAR and CCKBR in mammalian brain development.

Authors:  Sayoko Nishimura; Kaya Bilgüvar; Keiko Ishigame; Nenad Sestan; Murat Günel; Angeliki Louvi
Journal:  PLoS One       Date:  2015-04-15       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.